Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical is dominating the field of robotic surgery with its innovative da Vinci systems and a rapidly expanding presence in both US and international markets. The company is well-positioned to benefit from the growing demand for minimally invasive surgical procedures, driven by public health concerns, workforce shortages, and patient preferences. While there may be some near-term margin compression and competitive pressures, the company's strong operating leverage and continued investment in new platforms and initiatives make it a compelling long-term investment opportunity.

Intuitive Surgical is facing several key risks that could affect its stock price in the long term. These include the potential disruptions to the global healthcare system caused by the ongoing COVID-19 pandemic, the slower adoption of new products, and declines in underlying procedure volumes. These factors, as well as increasing competition in the robotic surgery market and potential delays in product approvals, could put pressure on the company's growth and earnings. Despite strong 2Q results and a stable demand for its capital, the company's guidance for the remainder of the fiscal year is concerning, with slower procedure growth in the U.S. and limited visibility for upside. Additionally, with a lower ASP and lower mix of placements in the U.S. compared to overseas, there are questions about the sustainability of its growth and profitability. As a result of these risks and uncertainties, it may be prudent for investors to have a negative outlook on Intuitive Surgical's stock.